<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">inovmed</journal-id><journal-title-group><journal-title xml:lang="ru">Инновационная медицина Кубани</journal-title><trans-title-group xml:lang="en"><trans-title>Innovative Medicine of Kuban</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2541-9897</issn><publisher><publisher-name>Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.35401/2500-0268-2021-22-2-44-51</article-id><article-id custom-type="elpub" pub-id-type="custom">inovmed-419</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>COVID-19 после экстренного аорто-коронарного шунтирования: особенности течения послеоперационного периода и прогноз</article-title><trans-title-group xml:lang="en"><trans-title>COVID-19 after emergency coronary artery bypass grafting: features of the postoperative course and prognosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3868-8061</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Татаринцева</surname><given-names>З. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Tatarintseva</surname><given-names>Z. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татаринцева Зоя Геннадьевна, заведующая инфекционным отделением № 2, НИИ – ККБ № 1 им. проф. С.В. Очаповского; аспирант кафедры терапии № 1 факультета повышения квалификации и профессиональной переподготовки специалистов, Кубанский государственный медицинский университет</p><p>350086, Краснодар, ул. 1 Мая, 167</p></bio><bio xml:lang="en"><p>Zoya G. Tatarintseva, Head of the Infectious Diseases Department no. 4, Research Institute – Ochapovsky Regional Hospital no. 1; postgraduate student of the Department of Therapy no. 1 of the Faculty of Advanced Training and Professional Retraining of Specialists, Kuban State Medical University</p><p>167, 1st May St., Krasnodar, 350086</p></bio><email xlink:type="simple">z.tatarintseva@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8600-0199</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Космачева</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kosmacheva</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Космачева Елена Дмитриевна, доктор медицинских наук, заместитель главного врача по лечебной части, НИИ – ККБ № 1 им. проф. С.В. Очаповского; заведующая кафедрой терапии № 1 факультета повышения квалификации и профессиональной переподготовки специалистов, Кубанский государственный медицинский университет</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Elena D. Kosmacheva, Dr. of Sci. (Med.), Chief Medical Officer, Research Institute – Ochapovsky Regional Hospital no. 1; Head of the Department of Therapy no. 1 of the Faculty of Advanced Training and Professional Retraining of Specialists, Kuban State Medical University</p><p>Krasnodar</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6795-3506</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чумаченко</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chumachenko</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чумаченко Наталья Владимировна, врач-кардиолог, инфекционное отделение № 1</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Natalya V. Chumachenko, Cardiologist, Infectious Diseases Department no. 1</p><p>Krasnodar</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1394-3011</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Халафян</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khalafyan</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Халафян Александр Альбертович, доктор технических наук, профессор кафедры прикладной математики</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Alexander A. Khalafyan, Dr. of Sci. (Tech.), Professor, Department of Applied Mathematics</p><p>Krasnodar</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт – Краевая клиническая больница №1 им. проф. С.В. Очаповского;&#13;
Кубанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute – Ochapovsky Regional Hospital no. 1;&#13;
Kuban State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт – Краевая клиническая больница №1 им. проф. С.В. Очаповского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute – Ochapovsky Regional Hospital no. 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Кубанский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kuban State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2021</year></pub-date><volume>0</volume><issue>2</issue><fpage>44</fpage><lpage>51</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Татаринцева З.Г., Космачева Е.Д., Чумаченко Н.В., Халафян А.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Татаринцева З.Г., Космачева Е.Д., Чумаченко Н.В., Халафян А.А.</copyright-holder><copyright-holder xml:lang="en">Tatarintseva Z.G., Kosmacheva E.D., Chumachenko N.V., Khalafyan A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.innovmedkub.ru/jour/article/view/419">https://www.innovmedkub.ru/jour/article/view/419</self-uri><abstract><p>Введение Коронавирусная болезнь, вызванная вирусом SARS-CoV-2, идентифицированным в 2019 г. (COVID-19), вынуждает кардиологические отделения быстро адаптировать существующие клинические рекомендации к новой реальности, и это особенно касается маршрутизации пациентов с острым коронарным синдромом (ОКС). В статье продемонстрировано как COVID-19 влияет на неотложную кардиохирургическую помощь.</p><p>Цель работы Анализ особенностей завершенных случаев операций экстренного аорто-коронарного шунтирования (эАКШ) при инфекции COVID-19, диагностированной в послеоперационном периоде в НИИ – ККБ № 1 им проф. С.В. Очаповского за период с 1 мая 2020 по 1 февраля 2021 г.</p><p>Материал и методы Ретроспективно изучены завершенные случаи эАКШ. Экстренное аорто-коронарное шунтирование было выполнено 145 пациентам: 79 больным – с нестабильной стенокардией (НС), 40 – с Q-негативным инфарктом миокарда (ИМ), 14 – с первичным Q-позитивным ИМ, 12 – с повторным ИМ. Условием для проведения эАКШ был отрицательный результат ПЦР SARS-Cov-2 и отсутствие вирусной пневмонии по КТ. Обследуемые были распределены на 2 подгруппы. 1-я подгруппа – эАКШ у пациентов, за время послеоперационного наблюдения которых в стационаре не был диагностирован COVID-19. 2-я подгруппа – эАКШ + диагностированный во время госпитализации COVID-19.</p><p>Результаты При помощи таблиц сопряженности показано наличие статистически значимой взаимосвязи между принадлежностью к группе и летальностью, которая составила 2,3% (n = 3) – в 1-й подгруппе и 20% (n = 3) – во 2-й, критерий Пирсона χ2 = 10,6, p &lt; 0,05. При анализе выживаемости в подгруппе эАКШ + COVID-19 стоит обратить внимание на кумулятивную долю выживших с учетом тяжести протекания вирусной пневмонии. С КТ-4 к 32 дню пребывания в стационаре она составила 0,3.</p><p>Выводы Летальность в послеоперационном периоде после эАКШ при заражении СOVID-19 значимо выше. У пациентов, перенесших эАКШ и умерших в раннем и позднем послеоперационном периоде от COVID-19, новая коронавирусная инфекция диагностирована на более позднем сроке. В этих случаях выявлена значительно большая продолжительность искусственного кровообращения (ИК) и повышенный уровень ферритина на момент перевода в отделение обсервации. Выживаемость у пациентов, подвергшихся эАКШ в связи с первичным Q-негативным ИМ, гораздо ниже в сравнении с больными, госпитализированными по поводу нестабильной стенокардии.</p></abstract><trans-abstract xml:lang="en"><p>Introduction Coronavirus disease (COVID-19) caused by SARS-CoV-2 virus identified in 2019, forces cardiology departments to quickly adapt existing clinical guidelines to the new reality, and this is particularly relevant for scheduling patients with acute coronary syndrome (ACS). The article demonstrates how COVID-19 has affected emergency cardiac surgery care.</p><p>Objective To analyze the features of completed cases of emergency coronary artery bypass grafting (ECABG) and COVID-19 diagnosed during the postoperative period at the Research Institute – Ochapovsky Regional Hospital no. 1 for the period from May 1, 2020 to February 1, 2021. Material and Methods Completed cases of ECABG have been retrospectively studied. EACS was performed in 145 patients: in 79 people with unstable angina pectoris (NS), in 40 with Q-negative myocardial infarction (MI), in 14 cases with primary Q-positive MI, in 12 patients with recurrent MI. The condition for ECABG was a negative SARS-Cov-2 PCR result and the absence of viral pneumonia by CT. The patients were divided into 2 subgroups. The first one included people with ECABG that were not diagnosed with COVID-19 during postoperative follow-up in the hospital. Subgroup II had patients with ECABG and COVID-19 diagnosed during the hospitalization.</p><p>Results Contingency tables showed a statistically significant interaction between group membership and mortality, 2.3% (n = 3) in subgroup 1 and 20% (n = 3) in subgroup 2, Pearson’s test χ2 = 10.6, p &lt; 0.05. When analyzing survival rate in the EACS + COVID-19 subgroup, it is worth paying attention to the cumulative proportion of survivors, considering the severity of the course of viral pneumonia. The proportion of such patients with CT-4 by the 32nd day of hospital stay was 0.3.</p><p>Conclusions Mortality rate in the postoperative course after ECABG with COVID-19 is significantly higher. In patients who underwent ECABG and died in the early and late postoperative period from COVID-19, a new coronavirus infection was diagnosed at a later date. In these cases, a considerably longer duration of CPB and a higher level of ferritin were revealed at the time of transference to the observation department. Survival rate in ECABG patients due to primary Q-negative MI is significantly lower in comparison with patients hospitalized for unstable angina.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>острый коронарный синдром</kwd><kwd>COVID-19</kwd><kwd>летальный исход</kwd><kwd>аорто-коронарное шунтирование</kwd><kwd>кардиохирургические операции</kwd><kwd>сердечно-сосудистая хирургия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute coronary syndrome</kwd><kwd>COVID-19</kwd><kwd>mortality</kwd><kwd>coronary artery bypass grafting</kwd><kwd>cardiac surgery</kwd><kwd>cardiovascular surgery</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bonalumi G, di Mauro M, Garatti A, et al. Italian Society for Cardiac Surgery Task Force on COVID-19 Pandemic. The COVID-19 outbreak and its impact on hospitals in Italy: the model of cardiac surgery. Eur J Cardiothorac Surg. 2020;57(6):1025– 1028. PMID: 32301984. PMCID: PMC7184374. http://doi.org/10.1093/ejcts/ezaa151</mixed-citation><mixed-citation xml:lang="en">Bonalumi G, di Mauro M, Garatti A, et al. Italian Society for Cardiac Surgery Task Force on COVID-19 Pandemic. The COVID-19 outbreak and its impact on hospitals in Italy: the model of cardiac surgery. Eur J Cardiothorac Surg. 2020;57(6):1025– 1028. PMID: 32301984. PMCID: PMC7184374. http://doi.org/10.1093/ejcts/ezaa151</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fudulu DP, Angelini GD. Cardiac surgery in the time of the coronavirus. J Card Surg. 2020;35(6):1177-1179. PMID: 32333437. https://doi.org/10.1111/jocs.14580</mixed-citation><mixed-citation xml:lang="en">Fudulu DP, Angelini GD. Cardiac surgery in the time of the coronavirus. J Card Surg. 2020;35(6):1177-1179. PMID: 32333437. https://doi.org/10.1111/jocs.14580</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fukuhara S, Rosati CM, El-Dalati S. Acute type A aortic dissection during COVID-19 outbreak. Ann Thorac Surg. 2020;110:e405–e407. PMID: 32333849. https://doi.org/10.1016/j.athoracsur.2020.04.008</mixed-citation><mixed-citation xml:lang="en">Fukuhara S, Rosati CM, El-Dalati S. Acute type A aortic dissection during COVID-19 outbreak. Ann Thorac Surg. 2020;110:e405–e407. PMID: 32333849. https://doi.org/10.1016/j.athoracsur.2020.04.008</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/ angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc. 2020;9(7):e016219. PMID: 32233755. https://doi.org/10.1161/JAHA.120.016219</mixed-citation><mixed-citation xml:lang="en">Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/ angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc. 2020;9(7):e016219. PMID: 32233755. https://doi.org/10.1161/JAHA.120.016219</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-95. PMID: 32173574. https://doi.org/10.1016/j.ijid.2020.03.017</mixed-citation><mixed-citation xml:lang="en">Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-95. PMID: 32173574. https://doi.org/10.1016/j.ijid.2020.03.017</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. J Am Med Assoc. 2020;323(13):1239–1242. PMID: 32091533. https://doi.org/10.1001/jama.2020.2648</mixed-citation><mixed-citation xml:lang="en">Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. J Am Med Assoc. 2020;323(13):1239–1242. PMID: 32091533. https://doi.org/10.1001/jama.2020.2648</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bonow RO, Fonarow GC, O'Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751-753. PMID: 32219362. https://doi.org/10.1001/jamacardio.2020.1105</mixed-citation><mixed-citation xml:lang="en">Bonow RO, Fonarow GC, O'Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751-753. PMID: 32219362. https://doi.org/10.1001/jamacardio.2020.1105</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Br Med J. 2020;368:m1091. PMID: 32217556. https://doi.org/10.1001/jamacardio.2020.1105</mixed-citation><mixed-citation xml:lang="en">Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Br Med J. 2020;368:m1091. PMID: 32217556. https://doi.org/10.1001/jamacardio.2020.1105</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–1026. PMID: 32338827 https://doi.org/10.1111/jth.14810</mixed-citation><mixed-citation xml:lang="en">Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–1026. PMID: 32338827 https://doi.org/10.1111/jth.14810</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Spertus JA, Jones PG, Maron DJ, et al. Health-status outcomes with invasive or conservative care in coronary disease. N Eng J Med. 2020;382(15):1408–1419. PMID: 32227753. https://doi.org/10.1056/NEJMoa1916370</mixed-citation><mixed-citation xml:lang="en">Spertus JA, Jones PG, Maron DJ, et al. Health-status outcomes with invasive or conservative care in coronary disease. N Eng J Med. 2020;382(15):1408–1419. PMID: 32227753. https://doi.org/10.1056/NEJMoa1916370</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tribouilloy C, Rusinaru D, Bohbot Y, et al. How should very severe aortic stenosis be defined in asymptomatic individuals? J Am Heart Assoc. 2019;8(3):e011724. PMID: 30712451. https://doi.org/10.1161/JAHA.118.011724</mixed-citation><mixed-citation xml:lang="en">Tribouilloy C, Rusinaru D, Bohbot Y, et al. How should very severe aortic stenosis be defined in asymptomatic individuals? J Am Heart Assoc. 2019;8(3):e011724. PMID: 30712451. https://doi.org/10.1161/JAHA.118.011724</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Romiti S., Totaro M., Laderchi A, et al. Case Report: Emergency CABG Following Failure of PTCA in a COVID-19 Patient. Frontiers in Cardiovascular Medicine. 2021;7:620610. PMID: 33505996. https://doi.org/10.3389/fcvm.2020.620610</mixed-citation><mixed-citation xml:lang="en">Romiti S., Totaro M., Laderchi A, et al. Case Report: Emergency CABG Following Failure of PTCA in a COVID-19 Patient. Frontiers in Cardiovascular Medicine. 2021;7:620610. PMID: 33505996. https://doi.org/10.3389/fcvm.2020.620610</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Халафян А.А. STATISTICA 6. Математическая статистика с элементами теории вероятностей. М.: Бином; 2010.</mixed-citation><mixed-citation xml:lang="en">Khalafyan AA. STATISTICA 6. Mathematical statistics with elements of probability theory. Moscow: Binom; 2010. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Профилактика, диагностика и лечение новой коро- навирусной инфекции (COVID-19). Временные методические рекомендации Минздрава России, версия 10 (08.02.21). https://doi.org/10.18093/0869-0189-2019-29-6-655-672</mixed-citation><mixed-citation xml:lang="en">Temporary guidelines of the Ministry of Health of the Russian Federation, version 10 (08.02.21). (In Russ.). https://doi.org/10.18093/0869-0189-2019-29-6-655-672</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396(10243):27–38. PMID: 32479829. https://doi.org/10.1016/S0140-6736(20)31182-X</mixed-citation><mixed-citation xml:lang="en">COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396(10243):27–38. PMID: 32479829. https://doi.org/10.1016/S0140-6736(20)31182-X</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Barkhordari K, Khajavi MR, Bagheri J, et al. Early respiratory outcomes following cardiac surgery in patients with COVID-19. J Cardiac Surg. 2020;35(10):2479–2485. PMID: 32789988. https://doi.org/10.1111/jocs.14915</mixed-citation><mixed-citation xml:lang="en">Barkhordari K, Khajavi MR, Bagheri J, et al. Early respiratory outcomes following cardiac surgery in patients with COVID-19. J Cardiac Surg. 2020;35(10):2479–2485. PMID: 32789988. https://doi.org/10.1111/jocs.14915</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fattouch К, Corrao S, Augugliaro Е. еt al. Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): A case-series report. J Thorac Cardiovasc Surg. 2020;S0022- 5223(20)32872-5. https://doi.org/10.1016/j.jtcvs.2020.09.138</mixed-citation><mixed-citation xml:lang="en">Fattouch К, Corrao S, Augugliaro Е. еt al. Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): A case-series report. J Thorac Cardiovasc Surg. 2020;S0022- 5223(20)32872-5. https://doi.org/10.1016/j.jtcvs.2020.09.138</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hedman A, Larsson PT, Alam M, et al. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? Int J Cardiol. 2007;120(1):108–114. PMID: 17141340. https://doi.org/10.1016/j.ijcard.2006.09.004</mixed-citation><mixed-citation xml:lang="en">Hedman A, Larsson PT, Alam M, et al. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? Int J Cardiol. 2007;120(1):108–114. PMID: 17141340. https://doi.org/10.1016/j.ijcard.2006.09.004</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Parolari A, Camera M, Alamanni F, et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg.2007;84(3):823–828. PMID: 17720383. https://doi.org/10.1016/j.athoracsur.2007.04.048</mixed-citation><mixed-citation xml:lang="en">Parolari A, Camera M, Alamanni F, et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg.2007;84(3):823–828. PMID: 17720383. https://doi.org/10.1016/j.athoracsur.2007.04.048</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass: part 1 – mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23(2):223–231. PMID: 18930659. https://doi.org/10.1053/j.jvca.2008.08.007</mixed-citation><mixed-citation xml:lang="en">Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass: part 1 – mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23(2):223–231. PMID: 18930659. https://doi.org/10.1053/j.jvca.2008.08.007</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kowalewski M, Fina D, Slomka A, et al. COVID-19 and ECMO: the interplay between coagulation and inflammation – a narrative review. Crit Care. 2020;24(1):205. PMID: 32384917. https://doi.org/10.1186/s13054-020-02925-3</mixed-citation><mixed-citation xml:lang="en">Kowalewski M, Fina D, Slomka A, et al. COVID-19 and ECMO: the interplay between coagulation and inflammation – a narrative review. Crit Care. 2020;24(1):205. PMID: 32384917. https://doi.org/10.1186/s13054-020-02925-3</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg. 1999;68(3):1107–1115. PMID: 10510030. https://doi.org/10.1016/s0003-4975(99)00781-x</mixed-citation><mixed-citation xml:lang="en">Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg. 1999;68(3):1107–1115. PMID: 10510030. https://doi.org/10.1016/s0003-4975(99)00781-x</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Shoman B, Omar AS, Alkhulaifi A, et al. Perioperative management of COVID 19 patients undergoing coronary artery bypass surgery. J Clin Anesth. 2020;67:110037. PMID: 32920345. https://doi.org/10.1016/j.jclinane.2020.110037</mixed-citation><mixed-citation xml:lang="en">Shoman B, Omar AS, Alkhulaifi A, et al. Perioperative management of COVID 19 patients undergoing coronary artery bypass surgery. J Clin Anesth. 2020;67:110037. PMID: 32920345. https://doi.org/10.1016/j.jclinane.2020.110037</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hussain A, Khan H, Lopez-Marco A, et al. Cardiac surgery in patients with confirmed COVID-19 infection: Early experience. J Card Surg. 2020;35(6):1351–1353. PMID: 32531128. https://doi.org/10.1111/jocs.14657</mixed-citation><mixed-citation xml:lang="en">Hussain A, Khan H, Lopez-Marco A, et al. Cardiac surgery in patients with confirmed COVID-19 infection: Early experience. J Card Surg. 2020;35(6):1351–1353. PMID: 32531128. https://doi.org/10.1111/jocs.14657</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Harky A, Chen R, Pullan M. Examining the impact of COVID-19 on cardiac surgery services: The lessons learned from this pandemic. J Card Surg. 2020;35(9):2364–2366. PMID: 32643830. https://doi.org/10.1111/jocs.14783</mixed-citation><mixed-citation xml:lang="en">Harky A, Chen R, Pullan M. Examining the impact of COVID-19 on cardiac surgery services: The lessons learned from this pandemic. J Card Surg. 2020;35(9):2364–2366. PMID: 32643830. https://doi.org/10.1111/jocs.14783</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Silveira LM, Guerreirо GP, Lisboa LA, et al. Coronary Artery Bypass Graft During the COVID-19 Pandemic. Braz. J. Cardiovasc. Surg. 2020:35(6):1003–1006. PMID: 33113324. https://doi.org/10.21470/1678-9741-2020-0283</mixed-citation><mixed-citation xml:lang="en">Silveira LM, Guerreirо GP, Lisboa LA, et al. Coronary Artery Bypass Graft During the COVID-19 Pandemic. Braz. J. Cardiovasc. Surg. 2020:35(6):1003–1006. PMID: 33113324. https://doi.org/10.21470/1678-9741-2020-0283</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Lei S, Jiang F, Su W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. Version 2. E Clinical Medicine. 2020;21:100331. PMID: 32292899. https://doi.org/10.1016/j.eclinm.2020.100331</mixed-citation><mixed-citation xml:lang="en">Lei S, Jiang F, Su W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. Version 2. E Clinical Medicine. 2020;21:100331. PMID: 32292899. https://doi.org/10.1016/j.eclinm.2020.100331</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Amodeo G, Bugada D, Franchi S, et al. Immune function after major surgical interventions: the effect of postoperative pain treatment. J Pain Res. 2018;11:1297–305. PMID: 30022848 https://doi.org/10.2147/JPR.S158230</mixed-citation><mixed-citation xml:lang="en">Amodeo G, Bugada D, Franchi S, et al. Immune function after major surgical interventions: the effect of postoperative pain treatment. J Pain Res. 2018;11:1297–305. PMID: 30022848 https://doi.org/10.2147/JPR.S158230</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg. 2006;141(11):1132–40. PMID: 17116807. https://doi.org/10.1001/archsurg.141.11.1132</mixed-citation><mixed-citation xml:lang="en">Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg. 2006;141(11):1132–40. PMID: 17116807. https://doi.org/10.1001/archsurg.141.11.1132</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
